patent 4 페이지

본문 바로가기
Home  >  Technology  >  Patents and Publications
  • Lee CH, Kim SO, Byun KS, Moon MS, Kim EO, Yeon JE, Yoo W, Hong SP. Predominance of Hepatitis B Virus YMDD Mutants is Prognostic of Viral DNA Breakthrough. Gatroenterology 2006; 130(4)1144-1152

  • Chung HJ, Yang JH, Hwang SH, Hong SP, Oh HB. The Comparison of Restriction Fragment Mass Polymorphism with Sequencing Method for the Hepatitis C Virus Genotyping. Korean J. Lab. Med. 2005; 25(5): 352-360.

  • Kim YJ, Kim SO, Chung HJ, Jee MS, Kim BG, Kim KM, Yoon JH, Lee HS, Kim CY, Kim S, Yoo W, Hong SP. Population Genotyping of Hepatitis C Virus by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis of Short DNA Fragments. C

  • Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. Evaluation of Methods for Monitoring Drug Resistance in Chronic Hepatitis B Patients during Lamivudine Therapy Based on Mass Spectrometry and Reverse Hybridization. Antiv

  • Byon SH, Oh HS, Ahn BY, Hong SP, Kim JK, Kwon OW. Single Nucleotide Polymorphisms in the 3'-untranslated region of Vascular Endothelial Growth Factor in Diabetic Retinopathy. Korean J Ophthalmology 2005;46(11): 1911-1918.

  • Chang HY, Ahn SH, Kim do Y, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. Association between CCR5 Promoter Polymorphisms and Hepatitis B Virus Infection. Korean J Hepatol. 2005 11(2):116-24.

  • Kim OJ, Hong SP, Yim DJ, Kim HS, Kim WC, Ahn JY, Cho HJ, Hwang SG, Oh D, Kim NK. Thymidylate synthase enhancer region (TSER) polymorphism is a novel genetic determinant of hyperhomocysteinemia in ischemic stroke patients. Korean J Thrombo Hemostat 2004;11

  • Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon JY, Moon YM. Reappraisal of HBV Genotype and Clinical Significance in Korea Using MALDI-TOF Mass Spectrometry. Korean J. Hepatol. 2004;10(4): 260-270.

  • Sohn YH, Yoo SJ, Ynag JH, Hwang SH, Hong SP, Oh HB. The Comparison of Restriction Fragment Mass Polymorphism Method with Sequecing Method for the Detection of HBV YMDD Mutants. Korean J. Lab. Med. 2004; 24: 71-77.

  • Hong SP, Kim NK, Hwang SG, Chung HJ, Kim S, Han JH, Kim HT, Rim KS, Kang MS, Yoo W, Kim SO. Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J. Hepatol. 2004;40(5): 837-844.

  • Hong SP. Lamivudine resistance of hepatitis B virus: Mechanism and diagnosis. Korean J. Hepatol. 2003;9(S2):5-10. (review)

  • Kim NK, Hwang SG, Hong SP, Rhee HS, Chung HJ, Han JH, Kim HT, Rim KS, Yoo W, Kim SO. Novel mass spectrometric assay for monitoring drug resistance in hepatitis B virus during lamivudine therapy. Korean J. Genetics 2003;25 (1): 63-75.

  • Hong SP, Yoo W, Putnak E, Eckels KE, Rho HM, Kim SO. Nucleotide sequence of envelope protein of Japanese encephalitis virus SA14-14-2 adapted to Vero cells. DNA Sequence 2001;12:427-432.

  • Hong SP, Yoo WD, Putnak R, Srivastava AK, Eckels KH, Chung YJ, Rho HM, Kim SO. Preparation of a Purified, Inactivated Japanese Encephalitis (JE) Virus Vaccine in Vero Cells. Biotech. Letters 2001;23(19):1565-1573.

  • Srivastava AK., Putnak JR, Lee SH, Hong SP, Moon SB, Barvir DA, Zhao B, Olason RA, Kim S.O. Yoo W.D. Towle A.C., Vaughn D.W, Innis B.L. and Eckels K.E. Purified, Inactivated Japanese Encephalitis Vaccine made in Vero Cells. Vaccine 2001;19(31): 4557-45